Armata Pharmaceuticals ARMP
NYSE ARMP
$4.72 +0.30 (+6.67%)
As of: Aug 21, 2026 · 11:11 AM EDT

Armata Pharmaceuticals (ARMP) Non-Current Debt (2023 - 2026)

Armata Pharmaceuticals (ARMP) posted Non-Current Debt of $88.0 million for Q1 2026, down 14.64% sequentially from $103.1 million in Q4 2025.

Armata Pharmaceuticals (ARMP) Non-Current Debt (2023 - 2026) Analysis & Trends

Armata Pharmaceuticals has reported Non-Current Debt for 4 years, with the latest figure at $88.0 million in Q1 2026.

  • Quarterly Non-Current Debt changed N/A year-over-year to $88.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.0 million (changed N/A YoY) and the FY2025 annual result came in at $103.1 million, up 357.26% from the prior year.
  • Non-Current Debt eased to $88.0 million in Q1 2026 per ARMP's latest filing, from $103.1 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $103.1 million in Q4 2025 and troughed at $15.2 million in Q3 2025.
  • A 4-year average of $44.3 million and a median of $23.7 million in 2023 frame the typical range for Non-Current Debt.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Debt declined 4.79% in 2024, then jumped 357.26% in 2025.
  • Over 4 years, Non-Current Debt stood at $23.7 million in 2023, then retreated by 4.79% to $22.5 million in 2024, then surged by 357.26% to $103.1 million in 2025, then declined by 14.64% to $88.0 million in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $88.0 million, $103.1 million, and $15.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Vertex Pharmaceuticals 140.01 Bn 132.16 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.79 Bn 78.79 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 65.29 Bn 60.11 Bn 1.37 Bn -
4 Moderna 60.18 Bn 55.04 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 42.17 Bn 37.07 Bn 1.53 Bn 882.16 Mn
6 Alnylam Pharmaceuticals 31.55 Bn 28.24 Bn 992.69 Mn -
7 BioNTech SE 28.45 Bn 10.06 Bn 668.28 Mn 360.97 Mn
8 Insmed 27.45 Bn 26.29 Bn 358.27 Mn 546.77 Mn
9 Royalty Pharma 27.19 Bn 26.36 Bn - 8.96 Bn
10 Armata Pharmaceuticals 172.13 Mn 148.13 Mn - 42.02 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 42.02 Mn
Mar 31, 2026 87.98 Mn
Dec 31, 2025 103.06 Mn
Sep 30, 2025 15.24 Mn
Dec 31, 2024 22.54 Mn
Mar 31, 2024 35.37 Mn
Dec 31, 2023 23.67 Mn
Sep 30, 2023 22.28 Mn